Active Cellular Immunotherapy Disappoints in Metastatic Pros

In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo

Related Keywords

Loyola University Medical Center , Illinois , United States , Nevada , Massachusetts , Mike Bassett , Nicholas Vogelzang , Hitend Patel , Las Vegas , Stephanie Berg , Cancer Centers Of Nevada , Memorial Sloan Kettering Cancer Center , Comprehensive Cancer Centers ,